GlassScriptPhysician profile
Stephen Chandler
NPI 1386752723
$4,382.02
in general payments reported to CMS, 2019-2025
17 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $279 · 2021: $432 · 2022: $378 · 2023: $1,767 · 2024: $627 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446 · Travel and Lodging: $1,321 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,446.47 |
| Travel and Lodging | $1,320.98 |
| Education | $132.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,031.87 | 2019-2025 | Scopis Ent, Xpress Loprofile |
| Glaxosmithkline, LLC. | $587.30 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $414.90 | 2019-2025 | Dupixent |
| Optinose US, INC. | $367.98 | 2019-2022 | |
| Genzyme Corporation | $360.57 | 2019-2025 | |
| Intersect Ent, INC. | $332.91 | 2019-2021 | |
| Medtronic, INC. | $57.02 | 2021-2024 | Sinuva |
| Integra Lifesciences Corporation | $45.65 | 2022-2023 | Instruments-Orthopedic, Integra Duo, Microfrance |
| Smith+Nephew, INC. | $35.59 | 2023 | |
| Amgen INC. | $34.00 | 2025 | |
| Hikma Pharmaceuticals USA | $20.29 | 2025 | Ryaltris |
| Gebauer Company | $20.12 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.58 | 2025 | Tezspire |
| Ethicon US, LLC | $17.15 | 2025 | Vistaseal, Ethicon |
| Neurent Medical Limited | $15.58 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $13.94 | 2025 | Neffy |
| Phathom Pharmaceuticals, INC. | $9.57 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Chandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.